Gabriel Melo de Oliveira

Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man

Francisco Lopera, Claudia Mariño, Anita Chandrahas et al. · Nature Medicine · 2023 · 189 citations · Full text

Life Sciences, Genetics, Neurology +17

Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease Treatment

Denise da Gama Jaén Batista, Marcos Meuser Batista, Gabriel Melo de Oliveira et al. · Antimicrobial Agents and Chemotherapy · 2010 · 81 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Pharmacological Inhibition of Transforming Growth Factor β Signaling Decreases Infection and Prevents Heart Damage in Acute Chagas' Disease

Mariana Caldas Waghabi, Elen Mello de Souza, Gabriel Melo de Oliveira et al. · Antimicrobial Agents and Chemotherapy · 2009 · 69 citations · Full text

Life Sciences, Cardiology, Infectious Diseases +17

Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease

Fabiane Loiola de Oliveira, Tânia Cremonini de Araújo-Jorge, Elen Mello de Souza et al. · PLoS neglected tropical diseases · 2012 · 66 citations · Full text

Veterinary Medicine, Cardiology, Infectious Diseases +17

In Vitro and In Vivo Studies of the Trypanocidal Activity of a Diarylthiophene Diamidine against <i>Trypanosoma cruzi</i>

Cristiane França da Silva, Marcos Meuser Batista, Denise da Gama Jaén Batista et al. · Antimicrobial Agents and Chemotherapy · 2008 · 63 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17